Imaging patients is more costly when they move.
Patient motion during MR imaging results in added costs to radiology departments, according to a study published in the Journal of the American College of Radiology.
Researchers from the University of Washington and Harborview Medical Center in Seattle, performed a retrospective study to assess the prevalence, severity, and cost estimates associated with motion artifacts identified on clinical MR examinations.
The data were taken from a randomly selected full calendar week in April 2014 of MR images taken on three different scanners. The images were performed across a broad patient population with a wide range of illnesses. The authors noted that not all failed examinations were submitted to PACS, however they were available for review directly on the MR console.
Two blinded radiologists reviewed the data, using a scale of none to severe for clinical quantification of motion artifacts. Costs were calculated based on imaging time and the need for repeat imaging. A total of 192 completed clinical examinations were included in the study. The patients ranged in age from 21 to 87 with a mean age of 56; 97 were women, 95 men. One hundred eighteen image sequences were performed on outpatients, 76 on inpatients or through the emergency department. There were 68 repeat sequences in 38 patients. These took an average of 4 minutes, 10 seconds extra for each sequence, resulting in an added 278.5 minutes of additional scan time.
The results showed there were significant motion artifacts in 7.5% of the outpatient and 29.4% of inpatient and/or emergency department MR examinations. “The prevalence of repeat sequences was 19.8% of total MRI examinations,” the authors wrote. “The base-case cost estimate yielded a potential cost to the hospital of $592 per hour in lost revenue due to motion artifacts. Potential institutional average costs borne (revenue forgone) of approximately $115,000 per scanner per year may affect hospitals, owing to motion artifacts (univariate sensitivity analysis suggested a lower bound of $92,600, and an upper bound of $139,000).”
The researchers concluded that patient motion was a frequent cause of degradation of MR images, which added to substantial costs to the radiology department.
MRI or Ultrasound for Evaluating Pelvic Endometriosis?: Seven Takeaways from a New Literature Review
September 13th 2024While noting the strength of MRI for complete staging of disease and ultrasound’s ability to provide local disease characterization, the authors of a new literature review suggest the two modalities offer comparable results for diagnosing pelvic endometriosis.
Diffusion-Weighted MRI and Neoadjuvant Chemotherapy for Rectal Cancer: What New Research Reveals
September 3rd 2024In a comparison of imaging assessments to gauge the effectiveness of neoadjuvant chemotherapy for rectal adenocarcinoma, researchers found the combination of diffusion-weighted imaging and MR tumor regression grading had a 90 percent area under the curve (AUC) and a negative predictive value (NPV) of 93 percent.
FDA Expands Clearance of MRI-Guided AI Platform for Deep Brain Stimulation and Lesioning Techniques
September 3rd 2024Utilizing a new machine learning model, the OptimMRI software may improve radiosurgery applications and lesioning techniques such as MRI-guided focused ultrasound through enhanced targeting of the inferolateral part of the ventral intermediate nucleus (VIM).